Search research articles
Contact Us
Filters
Showing results (221-230 of 286) with videos related to
Page
of 29
Sort By:
Plos One
|
April 8, 2016
The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia
Platon Eliseev, Grigory Balantcev, Elena Nikishova, et al.
The American Journal of Clinical Nutrition
|
May 1, 1982
Hypercalcemia associated with parenteral amino acid and dextrose infusion
J E Gilligan, S Hagley, L I Worthley, et al.
Pilot and Feasibility Studies
|
April 3, 2023
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania
Stellah G Mpagama, Happiness C Mvungi, Peter M Mbelele, et al.
BMC Medicine
|
May 22, 2018
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis
S E Murthy, F Chatterjee, A Crook, et al.
Open Forum Infectious Diseases
|
November 25, 2024
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda
Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, et al.
Plos One
|
January 30, 2019
Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation
E N Bogdanova, A O Mariandyshev, G A Balantcev, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2019
Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening
Narges Alipanah, Priya B Shete, Hanh Nguyen, et al.
Journal of Clinical Microbiology
|
February 4, 2021
Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania
Peter M Mbelele, Emmanuel A Mpolya, Elingarami Sauli, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations
Ruth Bowness, Martin J Boeree, Rob Aarnoutse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials
Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Page
of 29
Search research articles
Search
Showing results (221-230 of 286) with videos related to
Sort By:
Page
of 29
Plos One
|
April 8, 2016
The Impact of a Line Probe Assay Based Diagnostic Algorithm on Time to Treatment Initiation and Treatment Outcomes for Multidrug Resistant TB Patients in Arkhangelsk Region, Russia
Platon Eliseev, Grigory Balantcev, Elena Nikishova, et al.
The American Journal of Clinical Nutrition
|
May 1, 1982
Hypercalcemia associated with parenteral amino acid and dextrose infusion
J E Gilligan, S Hagley, L I Worthley, et al.
Pilot and Feasibility Studies
|
April 3, 2023
Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania
Stellah G Mpagama, Happiness C Mvungi, Peter M Mbelele, et al.
BMC Medicine
|
May 22, 2018
Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis
S E Murthy, F Chatterjee, A Crook, et al.
Open Forum Infectious Diseases
|
November 25, 2024
Adverse Events Reported During Weekly Isoniazid-Rifapentine (3HP) Tuberculosis Preventive Treatment Among People With Human Immunodeficiency Virus in Uganda
Jillian L Kadota, Allan Musinguzi, Hélène E Aschmann, et al.
Plos One
|
January 30, 2019
Cost minimization analysis of line probe assay for detection of multidrug-resistant tuberculosis in Arkhangelsk region of Russian Federation
E N Bogdanova, A O Mariandyshev, G A Balantcev, et al.
Diagnostics (Basel, Switzerland)
|
June 2, 2019
Feasibility of Direct Sputum Molecular Testing for Drug Resistance as Part of Tuberculosis Clinical Trials Eligibility Screening
Narges Alipanah, Priya B Shete, Hanh Nguyen, et al.
Journal of Clinical Microbiology
|
February 4, 2021
Mycobactericidal Effects of Different Regimens Measured by Molecular Bacterial Load Assay among People Treated for Multidrug-Resistant Tuberculosis in Tanzania
Peter M Mbelele, Emmanuel A Mpolya, Elingarami Sauli, et al.
The Journal of Antimicrobial Chemotherapy
|
October 27, 2014
The relationship between Mycobacterium tuberculosis MGIT time to positivity and cfu in sputum samples demonstrates changing bacterial phenotypes potentially reflecting the impact of chemotherapy on critical sub-populations
Ruth Bowness, Martin J Boeree, Rob Aarnoutse, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 13, 2026
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials
Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, et al.
Page
of 29